Literature DB >> 16648267

Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo.

Bastiano Sanna1, Eric B Brandt, Robert A Kaiser, Paul Pfluger, Sandy A Witt, Thomas R Kimball, Eva van Rooij, Leon J De Windt, Marc E Rothenberg, Matthias H Tschop, Stephen C Benoit, Jeffery D Molkentin.   

Abstract

The calcium-activated phosphatase calcineurin is regulated by a binding cofactor known as modulatory calcineurin-interacting protein (MCIP) in yeast up through mammals. The physiologic function of MCIP remains an area of ongoing investigation, because both positive and negative calcineurin regulatory effects have been reported. Here we disrupted the mcip1 and mcip2 genes in the mouse and provide multiple lines of evidence that endogenous MCIP functions as a calcineurin facilitator in vivo. Mouse embryonic fibroblasts deficient in both mcip1/2 showed impaired activation of nuclear factor of activated T cells (NFAT), suggesting that MCIP is required for efficient calcineurin-NFAT coupling. Mice deficient in mcip1/2 showed a dramatic impairment in cardiac hypertrophy induced by pressure overload, neuroendocrine stimulation, or exercise, similar to mice lacking calcineurin Abeta. Moreover, simultaneous deletion of calcineurin Abeta in the mcip1/2-null background did not rescue impaired hypertrophic growth after pressure overload. Slow/oxidative fiber-type switching in skeletal muscle after exercise stimulation was also impaired in mcip1/2 mice, similar to calcineurin Abeta-null mice. Moreover, CD4(+) T cells from mcip1/2-null mice showed enhanced apoptosis that was further increased by loss of calcineurin Abeta. Finally, mcip1/2-null mice displayed a neurologic phenotype that was similar to calcineurin Abeta-null mice, such as increased locomotor activity and impaired working memory. Thus, a loss-of-function analysis suggests that MCIPs serve either a permissive or facilitative function for calcineurin-NFAT signaling in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648267      PMCID: PMC1464340          DOI: 10.1073/pnas.0509340103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

Review 1.  Calcineurin in memory and bidirectional plasticity.

Authors:  Isabelle M Mansuy
Journal:  Biochem Biophys Res Commun       Date:  2003-11-28       Impact factor: 3.575

Review 2.  The RCN family of calcineurin regulators.

Authors:  Zoe Hilioti; Kyle W Cunningham
Journal:  Biochem Biophys Res Commun       Date:  2003-11-28       Impact factor: 3.575

Review 3.  Transcriptional regulation by calcium, calcineurin, and NFAT.

Authors:  Patrick G Hogan; Lin Chen; Julie Nardone; Anjana Rao
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

4.  The JIP group of mitogen-activated protein kinase scaffold proteins.

Authors:  J Yasuda; A J Whitmarsh; J Cavanagh; M Sharma; R J Davis
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

5.  A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type.

Authors:  E R Chin; E N Olson; J A Richardson; Q Yang; C Humphries; J M Shelton; H Wu; W Zhu; R Bassel-Duby; R S Williams
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

6.  Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.

Authors:  Benjamin J Wilkins; Yan-Shan Dai; Orlando F Bueno; Stephanie A Parsons; Jian Xu; David M Plank; Fred Jones; Thomas R Kimball; Jeffery D Molkentin
Journal:  Circ Res       Date:  2003-12-01       Impact factor: 17.367

7.  The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin.

Authors:  Sandra Ryeom; Rebecca J Greenwald; Arlene H Sharpe; Frank McKeon
Journal:  Nat Immunol       Date:  2003-08-17       Impact factor: 25.606

8.  GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNs.

Authors:  Zoe Hilioti; Deirdre A Gallagher; Shalini T Low-Nam; Priya Ramaswamy; Pawel Gajer; Tami J Kingsbury; Christine J Birchwood; Andre Levchenko; Kyle W Cunningham
Journal:  Genes Dev       Date:  2003-12-30       Impact factor: 11.361

9.  Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction.

Authors:  Orlando F Bueno; Daniel J Lips; Robert A Kaiser; Benjamin J Wilkins; Yan-Shan Dai; Betty J Glascock; Raisa Klevitsky; Timothy E Hewett; Thomas R Kimball; Bruce J Aronow; Pieter A Doevendans; Jeffery D Molkentin
Journal:  Circ Res       Date:  2003-11-13       Impact factor: 17.367

10.  Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin and decreases calcipressin half-life.

Authors:  Lali Genescà; Anna Aubareda; Juan J Fuentes; Xavier Estivill; Susana De La Luna; Mercè Pérez-Riba
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

View more
  51 in total

1.  The RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators.

Authors:  Sara Martínez-Martínez; Lali Genescà; Antonio Rodríguez; Alicia Raya; Eulàlia Salichs; Felipe Were; María Dolores López-Maderuelo; Juan Miguel Redondo; Susana de la Luna
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-30       Impact factor: 11.205

Review 2.  Calcineurin signaling in the heart: The importance of time and place.

Authors:  Valentina Parra; Beverly A Rothermel
Journal:  J Mol Cell Cardiol       Date:  2016-12-20       Impact factor: 5.000

3.  Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy.

Authors:  Songcang Chen; Christopher S Law; Christopher L Grigsby; Keith Olsen; Ting-Ting Hong; Yan Zhang; Yerem Yeghiazarians; David G Gardner
Journal:  Circulation       Date:  2011-09-26       Impact factor: 29.690

Review 4.  Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.

Authors:  Yili Wu; Philip T T Ly; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

5.  Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.

Authors:  Cameron Donaldson; Sarah Eder; Corey Baker; Mark J Aronovitz; Alexandra Dabreo Weiss; Monica Hall-Porter; Feng Wang; Adam Ackerman; Richard H Karas; Jeffery D Molkentin; Richard D Patten
Journal:  Circ Res       Date:  2008-12-12       Impact factor: 17.367

6.  Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1).

Authors:  Luzhou Xing; Martha Salas; Hong Zhang; Julia Gittler; Thomas Ludwig; Chyuan-Sheng Lin; Vundavalli V Murty; Wayne Silverman; Ottavio Arancio; Benjamin Tycko
Journal:  Mamm Genome       Date:  2012-10-25       Impact factor: 2.957

7.  Knockdown of RCAN1.4 Increases Susceptibility to FAS-mediated and DNA-damage-induced Apoptosis by Upregulation of p53 Expression.

Authors:  Young Sun Kim; Hong Joon Lee; Chorong Jang; Ho-Shik Kim; Young-Jin Cho
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

8.  Domain architecture of the regulators of calcineurin (RCANs) and identification of a divergent RCAN in yeast.

Authors:  Sohum Mehta; Huiming Li; Patrick G Hogan; Kyle W Cunningham
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

9.  A model selection approach to discover age-dependent gene expression patterns using quantile regression models.

Authors:  Joshua W K Ho; Maurizio Stefani; Cristobal G dos Remedios; Michael A Charleston
Journal:  BMC Genomics       Date:  2009-12-03       Impact factor: 3.969

10.  Glucocorticoid evoked upregulation of RCAN1-1 in human leukemic CEM cells susceptible to apoptosis.

Authors:  Yasuko Hirakawa; Laura J Nary; Rheem D Medh
Journal:  J Mol Signal       Date:  2009-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.